0113 ecp LifeMine
BioCentury & Getty Images

Emerging Company Profile

LifeMine taps fungal genomes for new drug candidates 

Emerging Company Profile: Start-up led by Klausner and Verdine seeking drug candidates with new mechanisms

Led by Rick Klausner and Gregory Verdine, LifeMine plans to find drug candidates with new mechanisms by mining fungal genomes.

By Sandi Wong, Assistant Editor
Jan 13, 2021 | 10:08 PM GMT
Editor's note: This story has been updated to correct the amount LifeMine raised in its series A financing. Updated on Jan 20, 2021 at 2:37 AM GMT

Led by Rick Klausner and Gregory Verdine, LifeMine has found drug candidates with novel mechanisms

Read the full 670 word article

How to gain access

Continue reading with a
two-week free trial.